These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 3938525)
1. Expression of Ia antigens in a murine T-lymphoma variant. Graf L; Koch N; Schirrmacher V Mol Immunol; 1985 Dec; 22(12):1371-7. PubMed ID: 3938525 [TBL] [Abstract][Full Text] [Related]
2. Ia antigens and associated invariant chain are induced simultaneously in lines of T-dependent mast cells by recombinant interferon-gamma. Koch N; Wong GH; Schrader JW J Immunol; 1984 Mar; 132(3):1361-9. PubMed ID: 6420464 [TBL] [Abstract][Full Text] [Related]
3. Suggestive evidence that the highly metastatic variant ESb of the T-cell lymphoma Eb is derived from spontaneous fusion with a host macrophage. Larizza L; Schirrmacher V; Graf L; Pflüger E; Peres-Martinez M; Stöhr M Int J Cancer; 1984 Nov; 34(5):699-707. PubMed ID: 6500746 [TBL] [Abstract][Full Text] [Related]
4. Different expression of Lyt differentiation antigens and cell surface glycoproteins by a murine T lymphoma line and its highly metastatic variant. Altevogt P; Kurnick JT; Kimura AK; Bosslet K; Schirrmacher V Eur J Immunol; 1982 Apr; 12(4):300-7. PubMed ID: 6124426 [TBL] [Abstract][Full Text] [Related]
5. Resistance of metastatic tumor variants to tumor-specific cytotoxic T-lymphocytes not due to defects in expression of restricting major histocompatibility complex molecules in murine cells. Altevogt P; Leidig S; Heckl-Oestreicher B Cancer Res; 1984 Nov; 44(11):5305-13. PubMed ID: 6333273 [TBL] [Abstract][Full Text] [Related]
6. T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. Bianchi R; Fioretti MC; Romani L; Grohmann U; Cenci E; Puccetti P Int J Cancer; 1990 Oct; 46(4):653-7. PubMed ID: 2120136 [TBL] [Abstract][Full Text] [Related]
7. Distinct mechanisms regulate MHC class II gene expression in B cells and macrophages. Maffei A; Scarpellino L; Bernard M; Carra G; Jotterand-Bellomo M; Guardiola J; Accolla RS J Immunol; 1987 Aug; 139(3):942-8. PubMed ID: 3110290 [TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines. Wong GH; Clark-Lewis I; McKimm-Breschkin L; Harris AW; Schrader JW J Immunol; 1983 Aug; 131(2):788-93. PubMed ID: 6408189 [TBL] [Abstract][Full Text] [Related]
9. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. X. Immunoselection of tumor variants differing in tumor antigen expression and metastatic capacity. Schirrmacher V; Bosslet K Int J Cancer; 1980 Jun; 25(6):781-8. PubMed ID: 14768708 [TBL] [Abstract][Full Text] [Related]
10. Kinetics of Ii synthesis, processing, and turnover in n-butyrate-treated Burkitt's lymphoma cell lines which express or do not express class II antigens and in hairy leukemic cells. Spiro RC; Sairenji T; Humphreys RE J Immunol; 1985 May; 134(5):3539-49. PubMed ID: 3856614 [TBL] [Abstract][Full Text] [Related]
11. Cytogenetic changes during tumor progression towards invasion, metastasis and immune escape in the Eb/ESb model system. Dzarlieva R; Schirrmacher V; Fusenig NF Int J Cancer; 1982 Nov; 30(5):633-42. PubMed ID: 6961115 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of Ia and Ia-associated invariant chain in mouse tissues after in vivo treatment with IFN-gamma. Momburg F; Koch N; Möller P; Moldenhauer G; Butcher GW; Hämmerling GJ J Immunol; 1986 Feb; 136(3):940-8. PubMed ID: 3079804 [TBL] [Abstract][Full Text] [Related]
13. Antigenic variation in cancer metastasis: immune escape versus immune control. Schirrmacher V; Fogel M; Russmann E; Bosslet K; Altevogt P; Beck L Cancer Metastasis Rev; 1982; 1(3):241-74. PubMed ID: 6985248 [TBL] [Abstract][Full Text] [Related]
14. Mixed isotype class II antigen expression. A novel class II molecule is expressed on a murine B cell lymphoma. Spencer JS; Kubo RT J Exp Med; 1989 Mar; 169(3):625-40. PubMed ID: 2647893 [TBL] [Abstract][Full Text] [Related]
15. Cooperative effect of interferon-gamma and tumor necrosis factor-alpha on the induction of the class II antigen-associated invariant chain expression. Pessara U; Momburg F; Koch N Eur J Immunol; 1988 Nov; 18(11):1719-26. PubMed ID: 3144453 [TBL] [Abstract][Full Text] [Related]
16. Influences of gamma interferon on synovial fibroblast-like cells. Ia induction and inhibition of collagen synthesis. Amento EP; Bhan AK; McCullagh KG; Krane SM J Clin Invest; 1985 Aug; 76(2):837-48. PubMed ID: 2993365 [TBL] [Abstract][Full Text] [Related]
17. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes. Schirrmacher V; Bosslet K; Shantz G; Clauer K; Hübsch D Int J Cancer; 1979 Feb; 23(2):245-52. PubMed ID: 83969 [TBL] [Abstract][Full Text] [Related]
18. Modulation of class I and class II histocompatibility antigens on human T cell lines by IFN-gamma. Gerrard TL; Dyer DR; Zoon KC; zur Nedden D; Siegel JP J Immunol; 1988 May; 140(10):3450-5. PubMed ID: 2966196 [TBL] [Abstract][Full Text] [Related]
19. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy. Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722 [TBL] [Abstract][Full Text] [Related]
20. Expression and modulation of major histocompatibility antigens on murine primary brain tumor in vitro. Akbasak A; Oldfield EH; Saris SC J Neurosurg; 1991 Dec; 75(6):922-9. PubMed ID: 1941122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]